Uniphar plc (FRA:0NR)

Market Cap	1.04B
Revenue (ttm)	2.77B
Net Income (ttm)	64.20M
Shares Out	n/a
EPS (ttm)	0.24
PE Ratio	16.17
Forward PE	17.06
Dividend	0.02 (0.50%)
Ex-Dividend Date	Apr 24, 2025

Volume	n/a
Average Volume	2,716
Open	3.790
Previous Close	3.765
Day's Range	3.790 - 3.815
52-Week Range	1.814 - 3.885
Beta	n/a
RSI	62.94
Earnings Date	Sep 2, 2025

About Chimerix

Uniphar plc, together with its subsidiaries, operates as a diversified healthcare services company in the Republic of Ireland, the United Kingdom, the Netherlands, and internationally. It operates through three divisions: Uniphar Medtech, Uniphar Pharma, and Uniphar Supply Chain & Retail. The company provides sales, marketing, compliance, and distribution services to medical device manufacturers; high-value services across the life cycle of a pharmaceutical product; and healthcare professionals with access to medicines that cannot source throug...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1967
• Employees: 3,500
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 0NR

Financial Performance

In 2024, Uniphar's revenue was 2.77 billion, an increase of 8.51% compared to the previous year's 2.55 billion. Earnings were 64.20 million, an increase of 43.26%.